Sintusek Palittiya, Poovorawan Yong
Thai Pediatric Gastroenterology, Hepatology and Immunology Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok 10330, Thailand.
World J Hepatol. 2021 Jan 27;13(1):120-131. doi: 10.4254/wjh.v13.i1.120.
Infections and associated morbidity and mortality may be more frequent in children who have undergone liver transplant than in healthy children. Immunization strategies to prevent vaccine-preventable infections (VPIs) can effectively minimize this infection burden. However, data on age-appropriate immunization and VPIs in children after liver transplant in Asia are limited.
To evaluate the immunization status, VPIs and non-VPIs requiring hospitalization in children who have undergone a liver transplant.
The medical records of children who had a liver transplant between 2004 and 2018 at King Chulalongkorn Memorial Hospital (Bangkok, Thailand) were retrospectively reviewed. Immunization status was evaluated their vaccination books. Hospitalization for infections that occurred up to 5 years after liver transplantation were evaluated, and divided into VPIs and non-VPIs. Hospitalizations for cytomegalovirus and Epstein-Barr virus were excluded. Severity of infection, length of hospital stay, ventilator support, intensive care unit requirement, and mortality were assessed.
Seventy-seven children with a mean age of 3.29 ± 4.17 years were included in the study, of whom 41 (53.2%) were female. The mean follow-up duration was 3.68 ± 1.45 years. Fortyeight children (62.3%) had vaccination records. There was a significant difference in the proportion of children with incomplete vaccination according to Thailand's Expanded Program on Immunization (52.0%) and accelerated vaccine from Infectious Diseases Society of America (89.5%) ( < 0.001). Post-liver transplant, 47.9% of the children did not catch up with age-appropriate immunizations. There were 237 infections requiring hospitalization during the 5 years of follow-up. There were no significant differences in hospitalization for VPIs or non-VPIs in children with complete and incomplete immunizations. The risk of serious infection was high in the first year after receiving a liver transplant, and two children died. Respiratory and gastrointestinal systems were common sites of infection. The most common pathogens that caused VPIs were rotavirus, influenza virus, and varicella-zoster virus.
Incomplete immunization was common pre- and post-transplant, and nearly all children required hospitalization for non-VPIs or VPIs within 5 years post-transplant. Infection severity was high in the first year post-transplant.
肝移植患儿的感染及相关发病率和死亡率可能比健康儿童更高。预防疫苗可预防感染(VPI)的免疫策略能有效减轻这种感染负担。然而,亚洲肝移植患儿中适合其年龄的免疫接种及VPI的数据有限。
评估肝移植患儿的免疫状况、VPI及需要住院治疗的非VPI。
回顾性分析2004年至2018年在朱拉隆功国王纪念医院(泰国曼谷)接受肝移植患儿的病历。通过他们的疫苗接种本评估免疫状况。对肝移植后5年内发生的感染住院情况进行评估,并分为VPI和非VPI。排除巨细胞病毒和EB病毒感染的住院情况。评估感染的严重程度、住院时间、呼吸机支持、重症监护病房需求及死亡率。
77名平均年龄为3.29±4.17岁的儿童纳入研究,其中41名(53.2%)为女性。平均随访时间为3.68±1.45年。48名儿童(62.3%)有疫苗接种记录。根据泰国扩大免疫规划(52.0%)和美国传染病学会加速疫苗接种方案(89.5%),未完成疫苗接种的儿童比例存在显著差异(P<0.001)。肝移植后,47.9%的儿童未补种适合其年龄的疫苗。在5年随访期间,有237次感染需要住院治疗。完成和未完成免疫接种的儿童在VPI或非VPI住院方面无显著差异。肝移植后的第一年严重感染风险很高,有两名儿童死亡。呼吸道和胃肠道系统是常见的感染部位。导致VPI的最常见病原体是轮状病毒、流感病毒和水痘-带状疱疹病毒。
移植前后未完成免疫接种情况常见,几乎所有儿童在移植后5年内因非VPI或VPI需要住院治疗。移植后第一年感染严重程度较高。